The first Novartis AG trade was made in Q4 2011.
Since then Chris Davis bought shares fourteen more times and sold shares on fifteen occasions. The investor completely sold their stake between Q3 2021 and Q4 2022.
Avg closing price
Price range
Sold -28.9 Thousand shares
Q4 2022
Avg closing price
$84.23
Price range
$75.31
-
$92.53
Sold 11.4% shares (-3.71 Thousand shares)
Q2 2022
Avg closing price
$87.73
Price range
$80.52
-
$93.75
Sold 24.1% shares (-10.4 Thousand shares)
Q1 2022
Avg closing price
$86.58
Price range
$80.11
-
$90.62
Sold 4.3% shares (-1.93 Thousand shares)
Q4 2021
Avg closing price
$83.03
Price range
$79.70
-
$88.13
Sold 4.1% shares (-1.92 Thousand shares)
Q3 2021
Avg closing price
$89.96
Price range
$81.78
-
$95.14
Increased shares by 5.5% (+2.46 Thousand shares)
Q2 2021
Avg closing price
$89.05
Price range
$85.24
-
$94.15
Increased shares by 7.7% (+3.17 Thousand shares)
Q1 2021
Avg closing price
$89.74
Price range
$83.50
-
$98.47
Increased shares by 6.2% (+2.41 Thousand shares)
Q4 2020
Avg closing price
$87.38
Price range
$78.07
-
$94.43
Increased shares by 2.3% (+860 shares)
Q3 2020
Avg closing price
$86.63
Price range
$82.14
-
$91.00
Increased shares by 36.5% (+10.1 Thousand shares)
Q2 2020
Avg closing price
$86.32
Price range
$80.93
-
$91.10
Increased shares by 6.6% (+1.72 Thousand shares)
Q1 2020
Avg closing price
$89.22
Price range
$70.67
-
$99.01
Increased shares by 8.6% (+2.06 Thousand shares)
Q4 2019
Avg closing price
$89.73
Price range
$84.35
-
$95.37
Increased shares by 4.5% (+1.03 Thousand shares)
Q3 2019
Avg closing price
$89.79
Price range
$85.54
-
$94.26
Increased shares by 8.1% (+1.72 Thousand shares)
Q2 2019
Avg closing price
$84.47
Price range
$75.40
-
$92.80
Increased shares by 37.8% (+5.85 Thousand shares)
Q1 2019